Form D · Other
Astrid Health Inc.
New York, NY · CIK 0001990492
Offering snapshot reported Oct 31, 2023 · SEC filing
- Reported sold
- $16.3M Offering amount: $16.3M
- Investors reported
- 24 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 18, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 31, 2023 | Initial | $16,294,994 | No comparison | 24 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-496205
Source: Form D, filed Oct 31, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rachel Blank | Director, Executive |
| Frederique Dame | Director |
Issuer details
Industry: Other (See others in industry)
Address:
769 Broadway #1019
New York, NY, 10003
New York, NY, 10003